NVAX
NASDAQ · Biotechnology
Novavax Inc
$9.62
-0.12 (-1.23%)
Open$9.84
Previous Close$9.74
Day High$10.00
Day Low$9.42
52W High$11.97
52W Low$5.01
Volume—
Avg Volume5.09M
Market Cap1.71B
P/E Ratio5.01
EPS$1.77
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+200.2% upside
Current
$9.62
$9.62
Target
$28.88
$28.88
$20.35
$28.88 avg
$29.25
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 749.60M | 891.22M | 441.16M |
| Net Income | -206,034,504 | -220,462,553 | -6,729,988 |
| Profit Margin | -27.5% | -26.1% | -1.5% |
| EBITDA | -118,720,693 | -134,091,853 | -8,036,743 |
| Free Cash Flow | — | — | -9,195,591 |
| Rev Growth | -15.9% | -15.9% | +6.7% |
| Debt/Equity | 0.75 | 0.75 | 0.98 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |